Published: 29 September 2026  (Updated: 29 September 2026)

European Chemical Agency (ECHA) and Health and Safety Executive (HSE) Update: September 2026

ECHA Updates

Harmonised Classification and Labelling

  • Trimethylolpropane
    No entry in CPR
    CMR 1B (repr) (Re-entered in RoI 16.06.26, expected submission 31.12.26)
    No interest in defence
  • Methylparaben
    Annex V entry 12
    classification not yet specified (expected submission 31.03.27)
  • Climbazole
    Annex V entry 32 and Annex III entry 310
    ED envi (submitted 30.07.26)
    Interest in defence TBC
  • Padimate O, ethyl dimethyl PABA, Ethylhexyl Dimethyl PABA
    Annex VI entry 21
    CMR 1B (submitted 22.05.26)
    No interest in defence
  • Dimethyl Imidazolidinone
    No entry in CPR
    CMR1B (repr)(legal deadline for opinion adoption 01.12.27)
    No interest in defence
  • Dioxolane
    (submitted by manufacturer 28.07.26)
    No interest in defence
  • Propylparaben
    Annex V entry 12
    ED envi 1
    RAC opinion 08.09.26 (not available online yet)
    Defence led by Cosmetics Europe
  • Spearmint oil
    No entry in CPR Annexes
    CMR 2 (repr) (RAC adopted CMR 2 06.26, opinion not yet available)
    Defence led by IFRA
  • Carvone
    No entry in CPR
    CMR 2 (repr) (RAC adopted CMR 2 06.26, opinion not yet available)
    Defence led by IFRA
  • Resorcinol
    Annex III entry 22
    ED HH 1 (RAC opinion adopted 05.06.26)

Restrictions

  • Octocrylene
    Annex VI entry 10
    restriction (environment) (deadline for comment on SEAC draft opinion 17.08.26)

SVHCs/Authorisations

No updates.

 

HSE Updates

Mandatory Classification and Labelling

  • Acetophenone
    No Annex entry
    Final opinion published
    CMR 1B (reprotox)
    EU ingredient defence led by independent applicant; TBC for GB defence
  • Diacetone alcohol
    No Annex entry
    Technical report published
    CMR 1B (reprotox)
    No interest in defence
  • Aminomethylpropanol
    No Annex entry
    Technical report published
    CMR 1B (reprotox)
    No interest in defence
  • Galaxolide
    No Annex entry
    Technical report published
    CMR 1B (reprotox)
    No interest in defence

 

 

 

Find us on...